VIROGIN BIOTECH
Virogin Biotech Ltd. ("Virogin") was founded in 2015, with the headquarters located in Vancouver, Canada. They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.
VIROGIN BIOTECH
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.virogin.com
Total Employee:
51+
Status:
Active
Contact:
+86 (755) 33122597
Email Addresses:
[email protected]
Total Funding:
204 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt
Similar Organizations
BioIntervene
BioIntervene is engages in drug discovery and development.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Medtrum
Medtrum is a diabetes management medical device developer.
Micot
Micot is a peptide and protein drug developer.
PegBio
PegBio is a Chinese innovative drug developer.
Percutek Therapeutics
Percutek Therapeutics is a medical device developer.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
China Life Healthcare Fund
China Life Healthcare Fund investment in Series D - Virogin Biotech
Linden Asset
Linden Asset investment in Series D - Virogin Biotech
CDH Investments
CDH Investments investment in Series C - Virogin Biotech
Shenzhen Xiaoxi Holdings
Shenzhen Xiaoxi Holdings investment in Series C - Virogin Biotech
China Merchants Venture Capital
China Merchants Venture Capital investment in Series C - Virogin Biotech
Korea Investment Partners
Korea Investment Partners investment in Series C - Virogin Biotech
CMG-SDIC Capital Management
CMG-SDIC Capital Management investment in Series C - Virogin Biotech
Peking University Mingde Fund
Peking University Mingde Fund investment in Series C - Virogin Biotech
Pan-Lin Capital
Pan-Lin Capital investment in Series C - Virogin Biotech
Purity Star
Purity Star investment in Series B - Virogin Biotech
Official Site Inspections
http://www.virogin.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Virogin Biotech"
Virogin Biotech - Crunchbase Company Profile
Virogin Biotech is an antineoplastic drug developer.View contacts for Virogin Biotech to access new leads and connect with decision-makers.See details»
Virogin Biotech - LinkedIn
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating …See details»
Virogin Biotech Company Profile - Office Locations, Competitors
Virogin Biotech has 5 employees across 2 locations. See insights on Virogin Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Virogin Biotech - 2025 Company Profile - Tracxn
Apr 27, 2025 Virogin Biotech is a series D company based in Vancouver (Canada), founded in 2015 by Chris Huang and William Jia. It operates as a Developed of drugs for the treatment of …See details»
Virogin Biotech Limited - VentureRadar
"Virogin Biotech was founded in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of highest medical need. We are a company …See details»
CNBG-Virogin Biotech (Shanghai) Ltd. - Drug pipelines, Patents ...
Explore CNBG-Virogin Biotech (Shanghai) Ltd. with its drug pipeline, therapeutic area, technology platform, 14 clinical trials, and 9 literature, Disease Domain:Infectious Diseases, Neoplasms, …See details»
Virogin Biotech Announces Dosing the First US Patient in a Phase …
Nov 15, 2022 Virogin Biotech is a clinical-stage biotech company developing next-generation immuno-oncolytic therapeutics to enhance systemic anti-tumor immunity. With over 170 …See details»
Virogin Biotech
Virogin Biotech is a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have developed two platforms: (1) innovative HSV-1 based …See details»
Virogin Biotech Canada Ltd Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Virogin Biotech Canada Ltd of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Virogin Biotech - Org Chart, Teams, Culture & Jobs | The Org
View Virogin Biotech's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Synapse - Global Drug Intelligence Database - Patsnap
May 8, 2025 Previously, Virogin Biotech licensed the China rights of VG161 to CNBG-Virogin. Both companies share research data, with CNBG-Virogin holding exclusive rights in China, …See details»
Team - Virogin
Our Team We are a company with over 50 employees and R&D facilities in Vancouver, Canada and Shanghai, China. ALL LAB LEADERSHIP ALL BIO BIO BIO BIO BIO LAB BIO BIO BIO …See details»
Virogin Biotech - Contacts, Employees, Board Members
Virogin Biotech is an antineoplastic drug developer.Virogin Biotech has 2 current employee profiles, including Co-Founder & Chief Executive Officer Chris Huang. Virogin Biotech has 1 …See details»
Virogin Biotech to Form a Joint Venture with China’s Largest ...
Chris Huang, Virogin’s CEO & Co-founder, commented, “We are very excited to be working with a reputable organization like CNBG to accelerate the development of our oncolytic virus …See details»
Virogin Biotech - Leadership Team | The Org
The Leadership Team at Virogin Biotech is responsible for setting the strategic direction of the company, driving innovation in oncolytic virus therapies, and ensuring alignment between …See details»
Virogin Biotech - Funding, Financials, Valuation & Investors
Virogin Biotech is funded by 19 investors. China Life Healthcare Fund and Linden Asset are the most recent investors. Which investors participated in the most funding rounds?See details»
Contact - Virogin
Partnerships Virogin aims to bring impactful therapeutic candidates to early clinical proof-of-concept for licensing and is committed to expand its pipeline through strategic collaborations. …See details»
Careers - Virogin
Careers Interested in a career at Virogin? Explore and apply to our current opportunities below. Company Culture Talent & Diversity Core Values Benefits & Well-being Career Development …See details»
Timeline - Virogin
Virogin Biotech was founded in 2015, with a vision to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of highest medical need.See details»
Independent assessment of the origins of SARS‑CoV‑2
1 day ago The Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) provided initial findings and recommendations to better understand the origins of SARS‑CoV‑2 in a …See details»